Master Pharm S.A.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-07-30
Share capital
215,000.00 PLN
Activity description

Master Pharm is a contract manufacturer of dietary supplements, cosmetics, and medical products. The company offers comprehensive project implementation services for dietary supplements, from concept to product, and develops product documentation at every stage of product rollout. They assist clients with product notifications to relevant authorities.

Registered address
ul. Wersalska 8, 91-203 Łódź, Poland
Email
Social media
Electronic delivery address
AE:PL-46735-73767-WFCAC-14

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$496,756

Filing timeliness

5 of 6 financial statements were filed late (the longest delay 91 days for 2023). All were audited by a statutory auditor.

  • 202520/07/2026
  • 202404/09/2025
  • 202314/10/2024
  • 202206/08/2023
  • 202118/07/2022
  • 202015/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Manufacture of food products88 / 765
Top 12%
Sector · Manufacturing516 / 11,958
Top 4.3%
City · Łódź180 / 8,056
Top 2.2%
Voivodeship · Łódzkie469 / 15,329
Top 3.1%
Country · Poland9,462 / 297,266
Top 3.2%

Results vs industry

Revenue
This companyUSD 23.12mMedianUSD 266.78kAverageUSD 5.34m
Net profit
This companyUSD 1.42mMedianUSD 2.11kAverageUSD 362.76k
Operating costs
This companyUSD 20.28mMedianUSD 276.57kAverageUSD 4.73m
Assets
This companyUSD 26.35mMedianUSD 219.08kAverageUSD 4.07m

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Tag Manager

Trademarks

The company holds 15 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2012.

MarkNumberClassesStatusProtected until
hepavetcomplex suplement diety Z.5610055Protected Sep 28, 2033
Witamina D3 2000 suplement diety Z.5610045Protected Sep 28, 2033
suplement diety witamina A+E avet Z.5610035Protected Sep 28, 2033
Morwa Biała suplement diety + Z.5610025Protected Sep 28, 2033
Sinavet suplement diety Z.5414255Protected Mar 25, 2032
MarkProtected until
hepavetcomplex suplement diety Sep 28, 2033
Witamina D3 2000 suplement diety Sep 28, 2033
suplement diety witamina A+E avet Sep 28, 2033
Morwa Biała suplement diety + Sep 28, 2033
Sinavet suplement diety Mar 25, 2032

Authorized Representatives

Wojciech Andrzej Furtak age 46 – President of the Management Board

Manner of representation

The following are authorized to represent the company and make declarations of will on behalf of the company: 1. in the case of a one-person management board, the President of the Management Board independently; 2. in the case of a multi-member management board, the President of the Management Board independently, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Supervisory board

Matthias Andreas Brommer – Supervisory Board Member
Sara Lesina – Supervisory Board Member
Marco Scomparin – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-11-21.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$119.6K
Buildings and premises
$1.5M

MSiG notices

Publication dateEvent
Jun 23, 2026Call to creditors

Public aid

9 public aid cases recorded, with a total value of $1,570,880.

PurposeGross amount
Regional investment aid
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

5 projects co-financed from European Funds recorded, with total EU co-financing of $543,750.

ProjectEU co-financing
Implementation of innovative vegan soft capsule technology
$169.9K
Development by Master Pharm S.A. of iron chelation technology to improve its bioavailability
$156.8K
Development of magnesium chelation technology by Master Pharm S.A.
$144K

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Prosuplement Group sp. z o.o.
Zakłady Farmaceutyczne Colfarm S.A.
Exim Pharma sp. z o.o.
Global Pharma Cm S.A.
Starpharma sp. z o.o.
Europharma Alliance sp. z o.o.
Puwer Polska sp. z o.o.
Nutramatic sp. z o.o.
Stella Nutrition sp. z o.o.
H+B Group sp. z o.o.

Change history

DateEvent
2016-05-18Share capital increase
2015-07-30Entered in the register

FAQ

Last updated: 2026-08-20